Actionable news
0
All posts from Actionable news
Actionable news in OCUL: OCULAR THERAPEUTIX Inc,

10 Biggest Mid-Day Gainers For Thursday

  • ContraVir Pharmaceuticals Inc (NASDAQ: CTRV) shares jumped 21.6 percent to $1.35 after the company disclosed positive interim data for CMX157 from its Phase 2a clinical study.
  • AEterna Zentaris Inc. (USA) (NASDAQ: AEZS) shares surged 19.7 percent to $4.55. AEterna Zentaris shares have slipped 45.71 percent over the past 52 weeks, while the S&P 500 index has gained 6.76 percent in the same period.
  • Ocular Therapeutix Inc (NASDAQ: OCUL) shares climbed 16.6 percent to $7.36 after the company revealed a tactical collaboration, option and license deal with Regeneron Pharmaceuticals Inc (NASDAQ: REGN). Ocular stock surged more than 25 percent. According to the agreement terms, the two companies would develop a sustained release formulation of aflibercept, which fits properly for clinical development advancement.
  • Lindsay Corporation (NYSE: LNN) gained 11.8 percent to $77.50. Lindsay reported Q4 earnings of $0.73 per share on revenue of $132.9 million.
  • PICO Holdings Inc (NASDAQ: PICO) shares rose 9.6 percent to $11.82. PICO reported the conclusion of Synthonics investigation and disclosed that its board has terminated John Hart as CEO of the company and Vidler Water.
  • Esperion Therapeutics Inc (NASDAQ: ESPR) shares climbed 9.6 percent to $13.50. Esperion Therapeutics disclosed that bempedoic acid global Phase 3 clinical program will include patients on any statin at any dose. The 1002-035 study also met its primary endpoint.
  • Long Island Iced Tea Corp (NASDAQ: LTEA) shares gained 9.3 percent to $5.06 after the company disclosed that it has entered into a partnership with Food Lion LLC.
  • Ulta Salon, Cosmetics & Fragrance, Inc. (NASDAQ: ULTA) surged 8.5 percent to $259.19 after the company boosted its EPS and comparable store sales forecast for the third quarter and full year.
  • Cara Therapeutics Inc (NASDAQ: CARA) shares gained 5.7 percent to $7.99. H.C. Wainwright initiated coverage on Cara Therapeutics with a Buy rating.
  • HCA Holdings Inc (NYSE: HCA) shares rose 3.1 percent to $79.24. KeyBanc upgraded HCA Holdings from Sector Weight to Overweight.

© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.